Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Centene Corporation stock logo
CNC
Centene
$63.87
+0.2%
$63.96
$25.08
$69.36
$31.52B1.076.07 million shs754,227 shs
TST
Telesta Therapeutics
C$0.00
C$0.69
C$0.14
N/AN/A212,584 shs292,300 shs
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
$277.19
+1.3%
$274.84
$208.77
$295.39
$6.27B1267,835 shs25,696 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Centene Corporation stock logo
CNC
Centene
+2.40%-0.34%-6.01%+20.29%+145.84%
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
+3.31%+0.21%-4.84%+7.21%+27.70%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Centene Corporation stock logo
CNC
Centene
$63.87
+0.2%
$63.96
$25.08
$69.36
$31.52B1.076.07 million shs754,227 shs
TST
Telesta Therapeutics
C$0.00
C$0.69
C$0.14
N/AN/A212,584 shs292,300 shs
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
$277.19
+1.3%
$274.84
$208.77
$295.39
$6.27B1267,835 shs25,696 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Centene Corporation stock logo
CNC
Centene
+2.40%-0.34%-6.01%+20.29%+145.84%
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
+3.31%+0.21%-4.84%+7.21%+27.70%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Centene Corporation stock logo
CNC
Centene
2.35
Hold$68.216.79% Upside
TST
Telesta Therapeutics
0.00
N/AN/AN/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
2.75
Moderate Buy$273.63-1.28% Downside

Current Analyst Ratings Breakdown

Latest TST, NXQ, CNC, and XAR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
Centene Corporation stock logo
CNC
Centene
Set Price Target$79.00
8/3/2026
Centene Corporation stock logo
CNC
Centene
Reiterated RatingOutperform$68.00 ➝ $79.00
7/29/2026
Centene Corporation stock logo
CNC
Centene
Set Price Target$66.00
7/29/2026
Centene Corporation stock logo
CNC
Centene
Reiterated RatingOverweight$75.00 ➝ $80.00
7/29/2026
Centene Corporation stock logo
CNC
Centene
UpgradeHoldStrong-Buy
7/29/2026
Centene Corporation stock logo
CNC
Centene
Boost Price TargetNeutral$46.00 ➝ $66.00
7/17/2026
Centene Corporation stock logo
CNC
Centene
Reiterated RatingSell (D)
7/14/2026
Centene Corporation stock logo
CNC
Centene
Reiterated RatingHold$47.00 ➝ $65.00
7/14/2026
Centene Corporation stock logo
CNC
Centene
Boost Price TargetBuy$71.00 ➝ $78.00
7/13/2026
Centene Corporation stock logo
CNC
Centene
Set Price TargetEqual Weight$56.00 ➝ $69.00
(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Centene Corporation stock logo
CNC
Centene
$202.94B0.16$4.81 per share13.28$40.76 per share1.57
TST
Telesta Therapeutics
N/AN/AN/AN/AN/AN/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Centene Corporation stock logo
CNC
Centene
-$6.67B-$10.44N/A12.450.33-2.51%12.12%3.20%N/A
TST
Telesta Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/AN/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
N/AN/A35.83N/AN/AN/AN/AN/AN/A

Latest TST, NXQ, CNC, and XAR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/28/2026Q2 2026
Centene Corporation stock logo
CNC
Centene
$1.09$2.51+$1.42$2.19$47.64 billion$53.58 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Centene Corporation stock logo
CNC
Centene
N/AN/AN/AN/AN/A
TST
Telesta Therapeutics
N/AN/AN/AN/AN/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
$0.800.29%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Centene Corporation stock logo
CNC
Centene
0.71
1.15
1.15
TST
Telesta Therapeutics
N/AN/AN/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Centene Corporation stock logo
CNC
Centene
93.63%
TST
Telesta Therapeutics
N/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
N/A

Insider Ownership

CompanyInsider Ownership
Centene Corporation stock logo
CNC
Centene
0.37%
TST
Telesta Therapeutics
N/A
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Centene Corporation stock logo
CNC
Centene
61,100494.00 million492.17 millionOptionable
TST
Telesta Therapeutics
147,000N/AN/ANot Optionable
SPDR S&P Aerospace & Defense ETF stock logo
XAR
SPDR S&P Aerospace & Defense ETF
N/A22.62 millionN/ANot Optionable

Recent News About These Companies

Cours SPDR S&P Aerospace & Defense ETF - USD

New MarketBeat Followers Over Time

Media Sentiment Over Time

Centene stock logo

Centene NYSE:CNC

$63.87 +0.11 (+0.18%)
As of 10:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Telesta Therapeutics TSE:TST

Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.

SPDR S&P Aerospace & Defense ETF stock logo

SPDR S&P Aerospace & Defense ETF NYSEARCA:XAR

$277.19 +3.56 (+1.30%)
As of 10:10 AM Eastern

The SPDR S&P Aerospace & Defense ETF (XAR) is an exchange-traded fund that mostly invests in industrials equity. The fund tracks an equal-weighted index of US aerospace & defense companies. XAR was launched on Sep 28, 2011 and is managed by State Street.